GB201402352D0 - Vaccines, polypeptides, and nucleic acids - Google Patents

Vaccines, polypeptides, and nucleic acids

Info

Publication number
GB201402352D0
GB201402352D0 GBGB1402352.7A GB201402352A GB201402352D0 GB 201402352 D0 GB201402352 D0 GB 201402352D0 GB 201402352 A GB201402352 A GB 201402352A GB 201402352 D0 GB201402352 D0 GB 201402352D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
polypeptides
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1402352.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GBGB1402352.7A priority Critical patent/GB201402352D0/en
Publication of GB201402352D0 publication Critical patent/GB201402352D0/en
Priority to EP19213015.1A priority patent/EP3693008A1/en
Priority to PCT/GB2015/050380 priority patent/WO2015121646A1/en
Priority to EP15705059.2A priority patent/EP3104876A1/en
Priority to US15/118,043 priority patent/US9994624B2/en
Priority to CA2939236A priority patent/CA2939236C/en
Priority to AU2015216783A priority patent/AU2015216783A1/en
Priority to JP2016568144A priority patent/JP2017512066A/ja
Priority to US15/974,290 priority patent/US10919944B2/en
Priority to AU2019222839A priority patent/AU2019222839B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB1402352.7A 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids Ceased GB201402352D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1402352.7A GB201402352D0 (en) 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids
JP2016568144A JP2017512066A (ja) 2014-02-11 2015-02-11 フィラリア線虫ワクチン、ポリペプチド、および核酸
US15/118,043 US9994624B2 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
PCT/GB2015/050380 WO2015121646A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
EP15705059.2A EP3104876A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
EP19213015.1A EP3693008A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
CA2939236A CA2939236C (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
AU2015216783A AU2015216783A1 (en) 2014-02-11 2015-02-11 Filarial nematode vaccines, polypeptides, and nucleic acids
US15/974,290 US10919944B2 (en) 2014-02-11 2018-05-08 Filarial nematode vaccines, polypeptides, and nucleic acids
AU2019222839A AU2019222839B2 (en) 2014-02-11 2019-08-28 Filarial nematode vaccines, polypeptides, and nucleic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1402352.7A GB201402352D0 (en) 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids

Publications (1)

Publication Number Publication Date
GB201402352D0 true GB201402352D0 (en) 2014-03-26

Family

ID=50390804

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1402352.7A Ceased GB201402352D0 (en) 2014-02-11 2014-02-11 Vaccines, polypeptides, and nucleic acids

Country Status (7)

Country Link
US (2) US9994624B2 (enExample)
EP (2) EP3693008A1 (enExample)
JP (1) JP2017512066A (enExample)
AU (2) AU2015216783A1 (enExample)
CA (1) CA2939236C (enExample)
GB (1) GB201402352D0 (enExample)
WO (1) WO2015121646A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids
WO2017173369A1 (en) 2016-04-01 2017-10-05 New York Blood Center, Inc. Biomakers and immunogenic compositions for filarial parasites
WO2017176950A2 (en) 2016-04-07 2017-10-12 Merial, Inc. Heartworm vaccine, methods and uses thereof
MX2024004078A (es) * 2021-10-04 2024-04-18 Agresearch Ltd Vacuna contra nematodos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265198B1 (en) 1994-05-26 2001-07-24 Heska Corporation Parasite astacin metalloendopeptidase proteins
MY160430A (en) 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis
US20130236490A1 (en) 2010-11-15 2013-09-12 The Board Of Trustees Of The University Of Illinois Multivalent Vaccine for Filariasis
GB201402352D0 (en) 2014-02-11 2014-03-26 Univ Liverpool Vaccines, polypeptides, and nucleic acids

Also Published As

Publication number Publication date
US9994624B2 (en) 2018-06-12
US10919944B2 (en) 2021-02-16
AU2019222839A1 (en) 2019-09-19
US20170051024A1 (en) 2017-02-23
CA2939236A1 (en) 2015-08-20
WO2015121646A1 (en) 2015-08-20
EP3693008A1 (en) 2020-08-12
EP3104876A1 (en) 2016-12-21
JP2017512066A (ja) 2017-05-18
AU2019222839B2 (en) 2021-07-08
US20180355002A1 (en) 2018-12-13
AU2015216783A1 (en) 2016-09-22
CA2939236C (en) 2023-02-21

Similar Documents

Publication Publication Date Title
IL275307B (en) Syntac polypeptides and their uses
GB201519584D0 (en) Nucleic acids, peptides and methods
DK3134131T3 (en) Nucleic acid vaccines
ZA201701851B (en) Fmdv recombinant vaccines and uses thereof
GB201405784D0 (en) Novel methods, polypeptides and uses thereof
IL287985A (en) A peptide derived from koc1 and a component containing it
GB201410031D0 (en) Polypeptides and uses thereof
GB201402352D0 (en) Vaccines, polypeptides, and nucleic acids
GB201608821D0 (en) Vaccines
PL3322718T3 (pl) Histonowe szczepionki przeciwnowotworowe
GB201414494D0 (en) Rhamnosyltransferase polypeptides and nucleic acids
GB201403359D0 (en) Nucleic acids and uses thereof
GB201403360D0 (en) Nucleic acids and uses thereof
GB201412646D0 (en) Proteins
GB201412648D0 (en) Proteins
GB201403912D0 (en) Proteins
GB201403913D0 (en) Proteins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)